Abstract
The non-canonical phosphorylation of the receptor tyrosine kinase ephrin type-A receptor 2 (EphA2) at Ser-897 plays crucial roles in tumor progression in a tyrosine kinase-independent manner. This phosphorylation is catalyzed by p90 ribosomal S6 kinase (RSK), a kinase downstream of extracellular signal-regulated kinase (ERK). We recently reported that stress-responsive kinase mitogen-activated protein kinase (MAPK)-activated protein kinase 2 (MK2), instead of ERK, regulates RSK under cellular stress conditions; however, the function of MK2 in ERK-activated cells is still unknown. We herein clarified that MK2 regulates the RSK-EphA2 axis in ERK-activated echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase (EML4-ALK) lung cancer cells. In addition, an MK2 inhibitor blocked enhancements in cell motility induced by the constitutively activated RSK-EphA2 axis. The present results reveal the importance of MK2 in the ERK-activated non-canonical activation of EphA2.
Original language | English |
---|---|
Pages (from-to) | 172-176 |
Number of pages | 5 |
Journal | Biological and Pharmaceutical Bulletin |
Volume | 48 |
Issue number | 2 |
DOIs | |
State | Published - 2025 |
Keywords
- Receptor, EphA2/metabolism
- Humans
- Lung Neoplasms/metabolism
- Cell Line, Tumor
- Protein Serine-Threonine Kinases/metabolism
- Intracellular Signaling Peptides and Proteins/metabolism
- Cell Movement
- Oncogene Proteins, Fusion/metabolism
- Phosphorylation
- Ribosomal Protein S6 Kinases, 90-kDa/metabolism